Related content

Reproterol – A Monomolecular Combination of Orciprenaline and Theophylline: Novel Aspects of Its Mode of Action in Asthma

By  

Respiration, Vol. 66, Iss. 3, 1999-06 ,pp. : 220-224

Karger

Access to resources Recommend Favorite

Indacaterol, a novel inhaled, once-daily, long-acting beta 2 -agonist for the treatment of obstructive airways diseases

By Beeh Kai  

Advances in Therapy, Vol. 26, Iss. 7, 2009-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite

Beta‐2 receptor agonist exposure in the uterus associated with subsequent risk of childhood asthma

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 28, Iss. 8, 2017-12 ,pp. : 746-753

John Wiley & Sons Inc

Access to resources Recommend Favorite

Addition of a 5-lipoxygenase-activating protein inhibitor to an inhaled corticosteroid (ICS) or an ICS/long-acting beta-2-agonist combination in subjects with asthma

By Snowise Neil G.   Clements Diane   Ho Shu-Yen   Follows Richard M.A.  

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1663-1674

Informa Healthcare

Access to resources Recommend Favorite

Long‐acting muscarinic antagonist + long‐acting beta agonist versus long‐acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta‐analysis

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 8, 2015-11 ,pp. : 1153-1159

John Wiley & Sons Inc

Access to resources Recommend Favorite